SELECTMD reports six months net profit of $312.90 million

August 16, 2022

Sagicor Select Fund Manufacturing & Distribution (SELECTMD) for the six months ended June 30, 2022 reported dividend income of $53.36 million (2021: $41.80 million). Interest income closed the six months period at $648,000 and relative to $890,000, last year. Gain on sale of financial assets at fair value through profit or loss amounted to $278.15 million relative to $930.39 million booked last year.

Net Investment income amounted to $332.15 million relative to $973.08 million booked last year.

Net foreign currency gains/ losses and other income amounted to $73,000 (2021: $50,000).

As such, total revenue for the six months under review equated $332.23 million relative to $973.13 million the previous year. The total income for the quarter amounted to $67.37 million relative to total income of $464.51 million twelve months earlier.

Total expenses for the six months period closed at $19.32 million (2021: $14.67 million), while for the quarter, expenses amounted to $10.94 million (2021: $6.92 million).

Consequently, net profit closed the six months period at $312.90 million relative to $958.46 million last year. Whereas the quarter net profit amounted to $56.43 million versus the net profit of $457.59 million booked last year.

Earnings per share for the period under review amounted to $0.08 relative to $0.25 in 2021, while for the quarter, SelectMD booked EPS of $0.01 versus an EPS of $0.12 in 2021. Twelve-month trailing EPS was $0.058. The number of shares used in this calculation was 3,816,612,000 shares. As at August 15, 2022 the stock traded at $0.59 with a P/E ratio of 10.18 times.

SELECTMD reported that, “During the six months of 2022, the fund saw a fair value gain on its financial assets of $278.1 million, benefitting from the price appreciation in manufacturing and distribution companies. Comparatively, for the six months of 2021, the fair value gain was $930.4 million, which was a larger gain than the six months of 2022, due to the low base effect of the COVID19 pandemic during the preceding financial year.”

Balance Sheet Highlights:

Total assets, as at June 30, 2022, amounted to $4.48 billion (2021: $4.24 billion). Of this, Financial assets at fair value through profit or loss totalled $4.23 billion (2021: $4.15 billion).

Total equity as at June 30, 2022 amounted to $4.38 billion (2021: $4.18 billion), resulting in a net asset value per share of $1.15 (2020: $1.10).



Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.